(VIAV) Viavi Solutions - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US9255501051
Stock: Network Testing, Monitoring, Assurance, Optical Security, Performance
Total Rating 63
Risk 33
Buy Signal 0.31
| Risk 5d forecast | |
|---|---|
| Volatility | 79.3% |
| Relative Tail Risk | -31.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.16 |
| Alpha | 147.22 |
| Character TTM | |
|---|---|
| Beta | 1.369 |
| Beta Downside | 1.513 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.19% |
| CAGR/Max DD | 0.99 |
EPS (Earnings per Share)
Revenue
Description: VIAV Viavi Solutions March 04, 2026
Viavi Solutions Inc. (VIAV) provides network test, monitoring, and assurance solutions globally. The company operates in the telecommunications sector, a capital-intensive industry driven by technological advancements and infrastructure development.
VIAV has two segments. The Network and Service Enablement (NSE) segment offers testing, monitoring, and security solutions for various network types, including wireless and wireline. This segments business model includes selling instruments, software licenses, and providing support services, typical for enterprise technology providers.
The Optical Security and Performance Products (OSP) segment utilizes optical coating technologies for anti-counterfeiting, 3D sensing, and aerospace applications. This segment serves specialized markets requiring high-precision optical components.
VIAV is also involved in quantum security development through a partnership with QuNu Labs. Investors may find further details on VIAVs financial performance and market position on ValueRay.
Headlines to watch out for
- Telecom capital expenditure directly impacts NSE segment revenue
- Optical security product demand drives OSP segment growth
- Global supply chain disruptions increase manufacturing costs
- Competition from larger network solution providers pressures margins
- Government and aerospace contract awards boost OSP segment sales
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -41.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -1.89 > 1.0 |
| NWC/Revenue: 63.44% < 20% (prev 62.80%; Δ 0.64% < -1%) |
| CFO/TA 0.04 > 3% & CFO 105.1m > Net Income -41.7m |
| Net Debt (564.3m) to EBITDA (90.9m): 6.21 < 3 |
| Current Ratio: 2.61 > 1.5 & < 3 |
| Outstanding Shares: last quarter (223.4m) vs 12m ago -0.62% < -2% |
| Gross Margin: 55.74% > 18% (prev 0.57%; Δ 5517 % > 0.5%) |
| Asset Turnover: 55.24% > 50% (prev 58.37%; Δ -3.13% > 0%) |
| Interest Coverage Ratio: 0.13 > 6 (EBITDA TTM 90.9m / Interest Expense TTM 72.5m) |
Altman Z'' -15.00
| A: 0.28 (Total Current Assets 1.28b - Total Current Liabilities 489.6m) / Total Assets 2.78b |
| B: -25.10 (Retained Earnings -69.73b / Total Assets 2.78b) |
| C: 0.00 (EBIT TTM 9.40m / Avg Total Assets 2.25b) |
| D: -35.93 (Book Value of Equity -69.84b / Total Liabilities 1.94b) |
| Altman-Z'' Score: -117.7 = D |
Beneish M -2.65
| DSRI: 1.10 (Receivables 320.5m/236.7m, Revenue 1.24b/1.01b) |
| GMI: 1.03 (GM 55.74% / 57.15%) |
| AQI: 1.28 (AQ_t 0.46 / AQ_t-1 0.36) |
| SGI: 1.24 (Revenue 1.24b / 1.01b) |
| TATA: -0.05 (NI -41.7m - CFO 105.1m) / TA 2.78b) |
| Beneish M-Score: -2.65 (Cap -4..+1) = A |
What is the price of VIAV shares?
As of March 11, 2026, the stock is trading at USD 29.72 with a total of 5,067,663 shares traded.
Over the past week, the price has changed by -10.05%, over one month by +8.74%, over three months by +54.79% and over the past year by +177.50%.
Over the past week, the price has changed by -10.05%, over one month by +8.74%, over three months by +54.79% and over the past year by +177.50%.
Is VIAV a buy, sell or hold?
Viavi Solutions has received a consensus analysts rating of 3.78.
Therefor, it is recommend to hold VIAV.
- StrongBuy: 4
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the VIAV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27.2 | -8.4% |
| Analysts Target Price | 27.2 | -8.4% |
VIAV Fundamental Data Overview March 07, 2026
P/E Forward = 33.4448
P/S = 5.7675
P/B = 9.0401
P/EG = 1.3402
Revenue TTM = 1.24b USD
EBIT TTM = 9.40m USD
EBITDA TTM = 90.9m USD
Long Term Debt = 1.22b USD (from longTermDebt, last quarter)
Short Term Debt = 65.0m USD (from shortTermDebt, last quarter)
Debt = 1.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 564.3m USD (from netDebt column, last quarter)
Enterprise Value = 7.74b USD (7.17b + Debt 1.33b - CCE 767.4m)
Interest Coverage Ratio = 0.13 (Ebit TTM 9.40m / Interest Expense TTM 72.5m)
EV/FCF = 98.29x (Enterprise Value 7.74b / FCF TTM 78.7m)
FCF Yield = 1.02% (FCF TTM 78.7m / Enterprise Value 7.74b)
FCF Margin = 6.33% (FCF TTM 78.7m / Revenue TTM 1.24b)
Net Margin = -3.35% (Net Income TTM -41.7m / Revenue TTM 1.24b)
Gross Margin = 55.74% ((Revenue TTM 1.24b - Cost of Revenue TTM 550.4m) / Revenue TTM)
Gross Margin QoQ = 55.32% (prev 56.00%)
Tobins Q-Ratio = 2.78 (Enterprise Value 7.74b / Total Assets 2.78b)
Interest Expense / Debt = 3.77% (Interest Expense 50.1m / Debt 1.33b)
Taxrate = 11.22% (4.40m / 39.2m)
NOPAT = 8.34m (EBIT 9.40m * (1 - 11.22%))
Current Ratio = 2.61 (Total Current Assets 1.28b / Total Current Liabilities 489.6m)
Debt / Equity = 1.59 (Debt 1.33b / totalStockholderEquity, last quarter 834.3m)
Debt / EBITDA = 6.21 (Net Debt 564.3m / EBITDA 90.9m)
Debt / FCF = 7.17 (Net Debt 564.3m / FCF TTM 78.7m)
Total Stockholder Equity = 766.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.85% (Net Income -41.7m / Total Assets 2.78b)
RoE = -5.44% (Net Income TTM -41.7m / Total Stockholder Equity 766.8m)
RoCE = 0.47% (EBIT 9.40m / Capital Employed (Equity 766.8m + L.T.Debt 1.22b))
RoIC = 0.52% (NOPAT 8.34m / Invested Capital 1.60b)
WACC = 9.77% (E(7.17b)/V(8.50b) * Re(10.96%) + D(1.33b)/V(8.50b) * Rd(3.77%) * (1-Tc(0.11)))
Discount Rate = 10.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.02%
[DCF] Terminal Value 70.87% ; FCFF base≈79.8m ; Y1≈75.5m ; Y5≈71.5m
[DCF] Fair Price = 1.66 (EV 948.4m - Net Debt 564.3m = Equity 384.1m / Shares 231.4m; r=9.77% [WACC]; 5y FCF grow -6.98% → 2.90% )
EPS Correlation: -18.10 | EPS CAGR: 0.0% | SUE: 4.0 | # QB: 2
Revenue Correlation: 1.42 | Revenue CAGR: 4.29% | SUE: 0.90 | # QB: 2
EPS current Year (2026-06-30): EPS=0.84 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+8 | Growth EPS=+77.8% | Growth Revenue=+35.1%
EPS next Year (2027-06-30): EPS=1.01 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+7 | Growth EPS=+20.5% | Growth Revenue=+10.6%
[Analyst] Revisions Ratio: +1.00 (8 Up / 0 Down within 30d for Current Year)
P/S = 5.7675
P/B = 9.0401
P/EG = 1.3402
Revenue TTM = 1.24b USD
EBIT TTM = 9.40m USD
EBITDA TTM = 90.9m USD
Long Term Debt = 1.22b USD (from longTermDebt, last quarter)
Short Term Debt = 65.0m USD (from shortTermDebt, last quarter)
Debt = 1.33b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 564.3m USD (from netDebt column, last quarter)
Enterprise Value = 7.74b USD (7.17b + Debt 1.33b - CCE 767.4m)
Interest Coverage Ratio = 0.13 (Ebit TTM 9.40m / Interest Expense TTM 72.5m)
EV/FCF = 98.29x (Enterprise Value 7.74b / FCF TTM 78.7m)
FCF Yield = 1.02% (FCF TTM 78.7m / Enterprise Value 7.74b)
FCF Margin = 6.33% (FCF TTM 78.7m / Revenue TTM 1.24b)
Net Margin = -3.35% (Net Income TTM -41.7m / Revenue TTM 1.24b)
Gross Margin = 55.74% ((Revenue TTM 1.24b - Cost of Revenue TTM 550.4m) / Revenue TTM)
Gross Margin QoQ = 55.32% (prev 56.00%)
Tobins Q-Ratio = 2.78 (Enterprise Value 7.74b / Total Assets 2.78b)
Interest Expense / Debt = 3.77% (Interest Expense 50.1m / Debt 1.33b)
Taxrate = 11.22% (4.40m / 39.2m)
NOPAT = 8.34m (EBIT 9.40m * (1 - 11.22%))
Current Ratio = 2.61 (Total Current Assets 1.28b / Total Current Liabilities 489.6m)
Debt / Equity = 1.59 (Debt 1.33b / totalStockholderEquity, last quarter 834.3m)
Debt / EBITDA = 6.21 (Net Debt 564.3m / EBITDA 90.9m)
Debt / FCF = 7.17 (Net Debt 564.3m / FCF TTM 78.7m)
Total Stockholder Equity = 766.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.85% (Net Income -41.7m / Total Assets 2.78b)
RoE = -5.44% (Net Income TTM -41.7m / Total Stockholder Equity 766.8m)
RoCE = 0.47% (EBIT 9.40m / Capital Employed (Equity 766.8m + L.T.Debt 1.22b))
RoIC = 0.52% (NOPAT 8.34m / Invested Capital 1.60b)
WACC = 9.77% (E(7.17b)/V(8.50b) * Re(10.96%) + D(1.33b)/V(8.50b) * Rd(3.77%) * (1-Tc(0.11)))
Discount Rate = 10.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.02%
[DCF] Terminal Value 70.87% ; FCFF base≈79.8m ; Y1≈75.5m ; Y5≈71.5m
[DCF] Fair Price = 1.66 (EV 948.4m - Net Debt 564.3m = Equity 384.1m / Shares 231.4m; r=9.77% [WACC]; 5y FCF grow -6.98% → 2.90% )
EPS Correlation: -18.10 | EPS CAGR: 0.0% | SUE: 4.0 | # QB: 2
Revenue Correlation: 1.42 | Revenue CAGR: 4.29% | SUE: 0.90 | # QB: 2
EPS current Year (2026-06-30): EPS=0.84 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+8 | Growth EPS=+77.8% | Growth Revenue=+35.1%
EPS next Year (2027-06-30): EPS=1.01 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+7 | Growth EPS=+20.5% | Growth Revenue=+10.6%
[Analyst] Revisions Ratio: +1.00 (8 Up / 0 Down within 30d for Current Year)